NCT02459080View on ClinicalTrials.gov

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL

Enrollment

619

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

TD-4208

DRUG

Placebo

Trial Locations (1)

97202

Allergy Associates Research Center (AARC), Portland

Sponsors

Lead Sponsor

Collaborators (1)

Theravance Biopharma

All Listed Sponsors

collaborator

Theravance Biopharma

INDUSTRY

lead

Mylan Inc.

INDUSTRY